Atlas Trials

Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer

Clinical trial NCT05288777 · RECRUITING

Trial details

NCT number
NCT05288777
Sponsor
University of Virginia
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Breast CancerBreast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage III
Start date
2022-07-11
Primary completion
2028-12-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.